BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1339192)

  • 1. Receptor changes and LTP: an analysis using aniracetam, a drug that reversibly modifies glutamate (AMPA) receptors.
    Staubli U; Ambros-Ingerson J; Lynch G
    Hippocampus; 1992 Jan; 2(1):49-57. PubMed ID: 1339192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective effects of aniracetam across receptor types and forms of synaptic facilitation in hippocampus.
    Xiao P; Staubli U; Kessler M; Lynch G
    Hippocampus; 1991 Oct; 1(4):373-80. PubMed ID: 1688280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peculiar form of potentiation in mossy fiber synapses.
    Staubli U
    Epilepsy Res Suppl; 1992; 7():151-7. PubMed ID: 1334660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aniracetam after LTP induction are suggestive of interactions on the kinetics of the AMPA receptor channel.
    Kolta A; Lynch G; Ambros-Ingerson J
    Brain Res; 1998 Mar; 788(1-2):269-86. PubMed ID: 9555053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing long-term depression with pharmacologically induced synaptic attenuations in young rat hippocampi.
    Xiao MY; Niu YP; Wigstrom H
    Synapse; 1997 Aug; 26(4):329-40. PubMed ID: 9215592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of action of aniracetam at synaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors: indirect and direct effects on desensitization.
    Lawrence JJ; Brenowitz S; Trussell LO
    Mol Pharmacol; 2003 Aug; 64(2):269-78. PubMed ID: 12869631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of AMPA receptor unitary conductance by synaptic activity.
    Benke TA; Lüthi A; Isaac JT; Collingridge GL
    Nature; 1998 Jun; 393(6687):793-7. PubMed ID: 9655394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional redistribution of AMPA but not NMDA receptors after perforant path simulation in the adult rat hippocampus in vivo.
    Moga DE; Shapiro ML; Morrison JH
    Hippocampus; 2006; 16(11):990-1003. PubMed ID: 17039486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unified model of the presynaptic and postsynaptic changes during LTP at CA1 synapses.
    Lisman J; Raghavachari S
    Sci STKE; 2006 Oct; 2006(356):re11. PubMed ID: 17033044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of extracellular potassium facilitates the induction of hippocampal long-term potentiation.
    Ballyk BA; Goh JW
    J Neurosci Res; 1992 Dec; 33(4):598-604. PubMed ID: 1484393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ameliorating effects of preadolescent aniracetam treatment on prenatal ethanol-induced impairment in AMPA receptor activity.
    Wijayawardhane N; Shonesy BC; Vaithianathan T; Pandiella N; Vaglenova J; Breese CR; Dityatev A; Suppiramaniam V
    Neurobiol Dis; 2008 Jan; 29(1):81-91. PubMed ID: 17916430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Channel gating kinetics and synaptic efficacy: a hypothesis for expression of long-term potentiation.
    Ambros-Ingerson J; Lynch G
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7903-7. PubMed ID: 8395058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of monomethylarsonic and monomethylarsonous acid on evoked synaptic potentials in hippocampal slices of adult and young rats.
    Krüger K; Straub H; Hirner AV; Hippler J; Binding N; Musshoff U
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):115-23. PubMed ID: 19371632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postnatal aniracetam treatment improves prenatal ethanol induced attenuation of AMPA receptor-mediated synaptic transmission.
    Wijayawardhane N; Shonesy BC; Vaglenova J; Vaithianathan T; Carpenter M; Breese CR; Dityatev A; Suppiramaniam V
    Neurobiol Dis; 2007 Jun; 26(3):696-706. PubMed ID: 17493826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of D1 dopamine receptors increases surface expression of AMPA receptors and facilitates their synaptic incorporation in cultured hippocampal neurons.
    Gao C; Sun X; Wolf ME
    J Neurochem; 2006 Sep; 98(5):1664-77. PubMed ID: 16800848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal dysfunction produces distinct alterations in synaptic alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid and N-methyl-D-aspartate receptor currents in hippocampus.
    Kanju PM; Parameshwaran K; Vaithianathan T; Sims CM; Huggins K; Bendiske J; Ryzhikov S; Bahr BA; Suppiramaniam V
    J Neuropathol Exp Neurol; 2007 Sep; 66(9):779-88. PubMed ID: 17805008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory and the brain: unexpected chemistries and a new pharmacology.
    Lynch G
    Neurobiol Learn Mem; 1998; 70(1-2):82-100. PubMed ID: 9753589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Joint application of the independent component analysis and the nonstationary fluctuation analysis for the investigation of early stages of long-term potentiation in the rat hippocampus].
    Khakhalin AS; Frolov AA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2005; 55(3):293-304. PubMed ID: 16033229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postsynaptic modulation of AMPA receptor-mediated synaptic responses and LTP by the type 3 ryanodine receptor.
    Shimuta M; Yoshikawa M; Fukaya M; Watanabe M; Takeshima H; Manabe T
    Mol Cell Neurosci; 2001 May; 17(5):921-30. PubMed ID: 11358488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
    Priestley T; Marshall GR; Hill RG; Kemp JA
    Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.